SBI Securities
CUE icon

SBI Securities’s Cue Biopharma CUE Stock Holding History

SBI Securities’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.47K Buy
+300
New +$6.78K ﹤0.01% 1862
2025
Q4 		– Hold
0
– -$1 – 4077
2025
Q3 		– Hold
0
– – – 4168
2025
Q1 		– Hold
0
– -$1 – 4148
2024
Q4 		– Hold
0
– – – 4073

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TFG Asset Management
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

SBI Securities's CUE Position: Q2 2026 in Review

SBI Securities opened a new position in Cue Biopharma (CUE) in Q2 2026: 300 shares worth $9.47K. The stake represents ﹤0.01% of the portfolio and ranks #1862 among its holdings.

50 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • SBI Securities held 300 shares of Cue Biopharma worth $9.47K as of Q2 2026.
  • Cue Biopharma was a new SBI Securities position in Q2 2026.
  • Cue Biopharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1862 holding.
  • 50 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.